Revisiting Beta-Blocker Therapy in Heart Failure with Preserved Ejection Fraction
<p dir="ltr">Heart failure with preserved ejection fraction (HFpEF) is a heterogenous disorder and tends to be predominant in elderly, female, and obese patients. HFpEF has been classified using various cut-offs of left ventricular ejection fraction in the published studies with a cu...
محفوظ في:
| المؤلف الرئيسي: | Rasha Kaddoura (12506936) (author) |
|---|---|
| مؤلفون آخرون: | Ashfaq Patel (16855122) (author) |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
COMMENT ON “Revisiting Beta-Blocker Therapy in Heart Failure with Preserved Ejection Fraction”, Current Problems in Cardiology (2023), doi: https://doi.org/10.1016/j.cpcardiol.2023.102203
حسب: Dr Rasha Kaddoura (17823434)
منشور في: (2024) -
Beta-blocker therapy in heart failure with preserved ejection fraction (B-HFpEF): a systematic review and meta-analysis
حسب: Dr. Rasha Kaddoura (17823428)
منشور في: (2024) -
Effectiveness of Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction Using Real-World Data: An Updated Systematic Review and Meta-Analysis
حسب: Alaa Rahhal (14150403)
منشور في: (2022) -
Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction in patients without diabetes in Qatar.
حسب: Dina Abushanab (10696501)
منشور في: (2024) -
Cost-Effectiveness Analysis of Sacubitril/Valsartan for Reducing the Use of Implantable Cardioverter-Defibrillator (ICD) and the Risk of Death in ICD-Eligible Heart Failure Patients with Reduced Ejection Fraction
حسب: Rasha Kaddoura (12506936)
منشور في: (2022)